These results indicated that the activity of AKT and ERK1/2 was substantially enhanced in response to stimulation with 10% FBS in MCT-PAH-PASMCs compared with that in Ctrl-PASMCs. The gene discussed is MAPK3; the disease is pulmonary arterial hypertension.